Changes in the expression pattern of the nitrergic system of ovine cerebellum affected by scrapie

J Neuropathol Exp Neurol. 2007 Mar;66(3):196-207. doi: 10.1097/01.jnen.0000248557.37832.b4.

Abstract

The constitutive and inducible isoforms of nitric oxide synthase (NOS) and the end-product of nitration, nitrotyrosine, were analyzed by immunohistochemistry, Western blotting, and enzymatic activity in sheep at different stages of the prion disease, scrapie. Four groups were studied: 1) nonaffected (control), 2) preclinical, 3) clinical, and 4) terminal. Constitutive neuronal NOS (nNOS) was the most abundant isoform present in cerebellar neurons of the sheep. Expression of nNOS increased in preclinical animals but diminished in the late stages of the disease. The Purkinje cells that usually are not immunoreactive for this protein became immunopositive in the clinical phase. In unaffected sheep, the inducible isoform (iNOS) was slightly positive in the Purkinje cells. As the disease progressed, the immunoreactivity of Purkinje neurons for iNOS increased. At the final stages, numerous iNOS-positive microglial cells were found in the molecular layer. There was a basal level of protein nitration in the cerebellum of unaffected sheep, especially in the molecular layer. As the disease progressed, the distal prolongations of the Purkinje cells and the astroglia became immunoreactive for nitrotyrosine. Our results suggest that the nitrergic system reacts to the progression of spongiform diseases and may be part of their pathogenesis mechanism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western / methods
  • Cerebellum / metabolism*
  • Gene Expression / physiology
  • Immunohistochemistry / methods
  • Nitric Oxide Synthase Type I / metabolism*
  • Nitric Oxide Synthase Type II / metabolism*
  • Scrapie / pathology*
  • Sheep
  • Tyrosine / analogs & derivatives*
  • Tyrosine / metabolism

Substances

  • 3-nitrotyrosine
  • Tyrosine
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type II